Featured

eRAPID improves patient self-management of cancer treatment side-effects



Published
Galina Velikova, MD, PhD, St. James's University Hospital Leeds, Leeds, UK, provides an overview of eRAPID, the electronic self-reporting of adverse events for patients during and after cancer treatment. A randomized clinical trial involving eRAPID demonstrated a benefit to patients in managing their symptoms without increasing hospital workload. This interview took place at the European Society for Medical Oncology (ESMO) Breast Cancer 2022 congress in Berlin, Germany.
Category
Health
Be the first to comment